GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » R1 RCM Inc (NAS:RCM) » Definitions » Days Sales Outstanding

R1 RCM (R1 RCM) Days Sales Outstanding : 42.92 (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is R1 RCM Days Sales Outstanding?

R1 RCM's average Accounts Receivable for the three months ended in Dec. 2023 was $271 Mil. R1 RCM's Revenue for the three months ended in Dec. 2023 was $575 Mil. Hence, R1 RCM's Days Sales Outstanding for the three months ended in Dec. 2023 was 42.92.

The historical rank and industry rank for R1 RCM's Days Sales Outstanding or its related term are showing as below:

RCM' s Days Sales Outstanding Range Over the Past 10 Years
Min: 4.93   Med: 26.6   Max: 42.88
Current: 42.72

During the past 13 years, R1 RCM's highest Days Sales Outstanding was 42.88. The lowest was 4.93. And the median was 26.60.

RCM's Days Sales Outstanding is ranked better than
52.97% of 640 companies
in the Healthcare Providers & Services industry
Industry Median: 46.205 vs RCM: 42.72

R1 RCM's Days Sales Outstanding increased from Dec. 2022 (42.68) to Dec. 2023 (42.92).


R1 RCM Days Sales Outstanding Historical Data

The historical data trend for R1 RCM's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

R1 RCM Days Sales Outstanding Chart

R1 RCM Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.77 29.50 34.60 42.19 42.88

R1 RCM Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.68 43.02 42.14 42.63 42.92

Competitive Comparison of R1 RCM's Days Sales Outstanding

For the Health Information Services subindustry, R1 RCM's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


R1 RCM's Days Sales Outstanding Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, R1 RCM's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where R1 RCM's Days Sales Outstanding falls into.



R1 RCM Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

R1 RCM's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (260.2 + 269.4) / 2 ) / 2254.2*365
=264.8 / 2254.2*365
=42.88

R1 RCM's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (271.6 + 269.4) / 2 ) / 575.1*365 / 4
=270.5 / 575.1*365 / 4
=42.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


R1 RCM  (NAS:RCM) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


R1 RCM Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of R1 RCM's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


R1 RCM (R1 RCM) Business Description

Traded in Other Exchanges
Address
434 West Ascension Way, 6th Floor, Murray, UT, USA, 84123
R1 RCM Inc is a provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers. Its services help healthcare providers generate sustainable improvements in their operating margins and cash flows while also enhancing patient, physician, and staff satisfaction for the customers, Its service offering consists of end-to-end RCM services for health systems, hospitals, and physician groups that provide comprehensive revenue cycle infrastructure to providers, including all revenue cycle personnel, technology solutions, and process workflow. The majority of the revenue comes from the operating fees received.
Executives
Dominic Nakis director 433 W ASCENSION WAY, SUITE 200, MURRAY UT 84123
Henneman John B Iii director 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Evans Richard B. Jr. officer: Principal Accounting Officer C/O ACCRETIVE HEALTH, INC., 401 N. MICHIGAN AVENUE, SUITE 2700, CHICAGO IL 60611
John M. Sparby officer: See Remarks C/O R1 RCM INC., 401 N. MICHIGAN AVENUE, SUITE 2700, CHICAGO IL 60611
Lee Rivas officer: President C/O R1 RCM INC., 434 W. ASCENSION WAY, 6TH FLOOR, MURRAY UT 84123
Kyle Hicok officer: Chief Commercial Officer 434 W. ASCENSION WAY, 6TH FLOOR, MURRAY UT 84123
Jennifer D. Williams officer: Chief Financial Officer 434 W. ASCENSION WAY, 6TH FLOOR, MURRAY UT 84123
Janie Wade director C/O R1 RCM INC., 434 W. ASCENSION WAY, 6TH FLOOR, MURRAY UT 84123
Tcp-asc Achi Series Lllp director, 10 percent owner 65 E 55TH ST 27TH FLOOR, TOWERBROOK CAPITAL PARTNERS L.P., NEW YORK NY 10022
Joseph Gerard Flanagan director, officer: Chief Executive Officer C/O NORTEL NETWORKS CORPORATION, 195 THE WEST MALL, TORONTO A6 M9C 5K1
Brian K. Dean director R1 RCM INC., 434 W. ASCENSION WAY, 6TH FLOOR, MURRAY UT 84123
Gary Steven Long officer: See Remarks 7050 BRIXTON PLACE, SUWANEE GA 30024
Michael C. Feiner director 1166 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK NY 10036
Matthew S. Holt director C/O NEW MOUNTAIN CAPITAL, LLC, 787 SEVENTH AVENUE, 49TH FLOOR, NEW YORK NY 10019
Bradford Kyle Armbrester director 311 ARSENAL STREET, WATERTOWN MA 02472